RCKT — ROCKET PHARMACEUTICALS INC

Ownership history in Man Group plc  ·  3 quarters on record

This page tracks every 13F SEC filing in which Man Group plc reported a position in ROCKET PHARMACEUTICALS INC (RCKT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2022 Q3)
Avg. % of fund
0.0%
First filed
2018 Q3
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 62,576 -43,450 -41.0% 0.00% $204K $3.26
2022 Q3 ADDED 106,026 +94,768 +841.8% 0.01% $1.7M $15.96
2018 Q3 INITIATED 11,258 — — 0.00% $277K —
% of Fund (quarterly)    RCKT price (monthly, adj. close)

Other funds also holding RCKT

As of 2025 Q4 — sorted by position size

Monaco Asset Management SAM 3Y 1.82% Lion Point Capital, LP 3Y 7Y 1.56% M28 Capital Management LP 3Y 0.98% Newtyn Management, LLC 3Y 7Y 0.98% Amitell Capital Pte Ltd 3Y 0.7% MPM BioImpact LLC 3Y 0.64% RTW INVESTMENTS, LP 3Y 7Y 0.62% Prosight Management, LP 3Y 7Y 0.54% Opaleye Management Inc. 3Y 7Y 0.44% MONIMUS CAPITAL MANAGEMENT, LP 0.32%
← Back to Man Group plc Holdings